Adam Simpson

Adam Simpson, PhD has a strong background in business development and medical affairs. Adam most recently served as the VP / Head of Business Development at Spark Therapeutics, Inc. Prior to that, they held positions at Novartis Institutes for BioMedical Research (NIBR) and Novartis Gene Therapies, where they were responsible for gene therapies business development and licensing. Before joining Novartis, they worked at AveXis, Inc. as a Senior Director in business development. Earlier in their career, they held the role of Head of Business Development and Medical Affairs at Dermavant Sciences and Business Development Analyst at Roivant Sciences, Inc. Adam Simpson has extensive experience in the pharmaceutical industry and a proven track record in leading successful business development initiatives.

Adam Simpson, PhD, holds a Doctor of Philosophy (PhD) degree in Molecular Biophysics and Biochemistry from Yale University. Prior to this, they completed their Bachelor of Arts (B.A.) in Chemistry at the University of North Carolina at Chapel Hill.